biotech companies

In a crowded biotech landscape full of potential, especially in advanced therapeutic medicinal products (ATMPs), companies must differentiate themselves from their competitors to raise much-needed capital from investors. This can be a challenge for biotech companies in the space, where some fall victim to the “valley of death,” where companies fail to transition from proof…